NCT02520219 2015-08-11
Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Phase 2 Unknown
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.